tiprankstipranks
Advertisement

MCOW - ETF AI Analysis

Compare

Top Page

MCOW

Pacer S&P MidCap 400 Quality FCF Aristocrats ETF (MCOW)

Rating:73Outperform
Price Target:
MCOW, the Pacer S&P MidCap 400 Quality FCF Aristocrats ETF, earns a solid overall rating thanks to several strong core holdings like Medpace, Neurocrine, Exelixis, Rambus, and Mueller Industries, which show robust financial performance, positive earnings sentiment, and generally favorable momentum and strategic positioning. However, some key positions such as Pure Storage, DocuSign, Manhattan Associates, Lattice Semiconductor, and Sterling Infrastructure face valuation concerns and periods of bearish or mixed technical signals, which temper the fund’s rating; the main risk factor is that many of its top holdings share high valuation and overbought or bearish technical conditions, making the ETF sensitive to market pullbacks.
Positive Factors
Strong Recent One-Month Performance
The ETF has shown strong gains over the past month, suggesting positive short-term momentum.
Leading Technology and Industrial Holdings
Several top positions in technology and industrial companies have delivered strong results, helping support the fund’s overall performance.
Sector Diversification Across the U.S. Market
Holdings spread across technology, industrials, health care, and several other sectors help reduce the impact if any one industry struggles.
Negative Factors
Higher Expense Ratio for a Passive ETF
The fund’s ongoing fee is on the higher side for an index-based ETF, which can slightly reduce long-term returns.
Concentration in Technology and Industrials
A large share of assets in just two sectors increases the risk that weakness in technology or industrial stocks could drag down the fund.
Mixed Performance Among Top Holdings
Some of the largest positions have shown weak or lagging performance this year, which can offset gains from stronger stocks.

MCOW vs. SPDR S&P 500 ETF (SPY)

MCOW Summary

MCOW is an ETF that follows the S&P MidCap 400 Quality FCF Aristocrats Index, focusing on mid-sized U.S. companies with strong, steady cash flow. It holds a mix of sectors, with a big tilt toward technology and industrials, and includes well-known names like DocuSign and Lattice Semiconductor. Investors might consider MCOW if they want growth potential from mid-cap stocks while still aiming for financially solid businesses and broad diversification across industries. A key risk is that it is heavily tilted toward mid-cap and tech-related companies, so its price can rise and fall more than the overall market.
How much will it cost me?The Pacer S&P MidCap 400 Quality FCF Aristocrats ETF (MCOW) has an expense ratio of 0.49%, meaning you’ll pay $4.90 per year for every $1,000 invested. This is slightly higher than average for passively managed ETFs, as it focuses on a niche strategy targeting mid-cap companies with strong free cash flow, which requires more specialized tracking.
What would affect this ETF?The MCOW ETF, with its focus on mid-cap companies in the U.S., could benefit from continued innovation and growth in the technology and industrial sectors, which make up a significant portion of its holdings. However, it may face challenges if interest rates rise, as this could increase borrowing costs for mid-sized companies or if economic conditions weaken, impacting consumer spending and business investments. Regulatory changes or sector-specific disruptions in technology or healthcare could also influence the ETF's performance.

MCOW Top 10 Holdings

MCOW is leaning heavily into U.S. mid-cap tech and industrial names, with Sterling Infrastructure and Lattice Semiconductor doing much of the heavy lifting as their shares keep climbing. Rambus and Exelixis are also adding steady fuel, helped by solid fundamentals and AI or pipeline tailwinds. On the flip side, DocuSign and Manhattan Associates are losing steam, with weaker recent trading acting like a brake on returns. Overall, this is a U.S.-only, quality-focused mid-cap play, but with a noticeable tilt toward tech-driven growth stories.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Everpure4.64%$49.44K$24.17B38.48%
64
Neutral
Lattice Semiconductor4.00%$42.60K$18.71B143.43%
71
Outperform
Sterling Infrastructure3.55%$37.84K$21.50B215.88%
71
Outperform
Medpace Holdings3.50%$37.36K$15.92B75.22%
79
Outperform
DocuSign3.01%$32.08K$8.74B-39.59%
71
Outperform
Manhattan Associates2.89%$30.81K$8.94B-21.99%
75
Outperform
Rambus2.85%$30.38K$12.21B77.54%
78
Outperform
Exelixis2.82%$30.05K$14.04B31.19%
78
Outperform
Neurocrine2.70%$28.75K$17.52B37.87%
80
Outperform
Jazz Pharmaceuticals2.42%$25.81K$15.29B127.00%
64
Neutral

MCOW Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price
Price Trends
50DMA
20.69
Positive
100DMA
19.83
Positive
200DMA
19.94
Positive
Market Momentum
MACD
0.18
Positive
RSI
49.71
Neutral
STOCH
39.63
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For MCOW, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 21.08, equal to the 50-day MA of 20.69, and equal to the 200-day MA of 19.94, indicating a neutral trend. The MACD of 0.18 indicates Positive momentum. The RSI at 49.71 is Neutral, neither overbought nor oversold. The STOCH value of 39.63 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for MCOW.

MCOW Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$1.08M0.49%
73
Outperform
$54.75M0.60%
72
Outperform
$46.71M0.80%
68
Neutral
$35.38M0.59%
69
Neutral
$8.11M0.35%
68
Neutral
$4.64M0.88%
69
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
MCOW
Pacer S&P MidCap 400 Quality FCF Aristocrats ETF
21.01
0.82
4.06%
PAMC
Pacer Lunt MidCap Multi-Factor Alternator ETF
KMID
Virtus KAR Mid-Cap ETF
MMID
MFS Active Mid Cap ETF
MCDS
JPMorgan Fundamental Data Science Mid Core ETF
EPMB
Harbor Mid Cap Core ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement